Conceptual foundations of pharmacoeconomic analysis of prevention technologies of chronic viral infections

Keywords: chronic viral infection, prevention, pharmacoeconomics, mathematical model

Abstract

The introduction of various technologies for the prevention of chronic viral infections into practice requires well-founded evidence of their effectiveness, which can be obtained using pharmacoeconomic methods and models that determine not only the effectiveness and feasibility of introducing preventive technologies, but also the socio-economic associated consequences. In this context, the development of a unified model for the pharmacoeconomic evaluation of medical technologies at all stages of the prevention of chronic viral infections is key to implementing optimal strategies for combating them for both individual groups and the entire population, developing recommendations for the rational use of diagnostic tests and viral vaccines, and determining the optimal level of pharmaceutical care for patients.

The aim of the work – development of a conceptual model of pharmacoeconomic analysis of technologies for the prevention of chronic viral infections.

Pharmacoeconomic evaluation of technologies for the prevention of chronic viral infections is possible on the basis of an analytical platform that determines the relationship between the target population to be prevented, and the effectiveness of intermediate and final results. The pharmacoeconomic analysis of technologies for the prevention of socially significant chronic viral infections was proposed to be carried out according to the developed algorithm.

Implementation of the proposed algorithm for pharmacoeconomic analysis of various technologies for the prevention of chronic viral infections was based on developed unified model of the spread of viral infection in the population, where individuals can be assigned to different clinical and epidemiological classes. This model was a combination of epidemiological and clinical prognostic approaches and can be used to predict and conduct pharmacoeconomic assessment of viral infection prevention technologies with a general decrease in the number of people in a particular epidemiological class when applying medical technology for a certain period of time. The presented concept allows to formulate the principles of pharmacoeconomic evaluation of technologies for the prevention of chronic viral infections. It was advisable to use the concept of quality of life in assessing the usefulness of the technologies under study, which allows to formalize the cost-utility coefficient, minimization of which determines pharmacoeconomic reasonable strategies for the prevention of chronic viral infections.

The developed concept is promising, and information technologies based on it can become a reliable source of information to support decision-making by health experts in the pharmacoeconomic evaluation of technologies for the prevention of chronic viral infections.

References

1. Petrenko V. I. Suchasnyi pohliad na problemu poiednanoi potriinoi infektsii: tuberkulozu, VIL/SNIDu, hepatytiv V i S // Tuberkuloz, lehenevi khvoroby, VIL-infektsiia. – 2012. – № 4. – S. 5–12.

2. Zaikova T. V. Stan informovanosti zhinochoho naselennia shchodo suchasnykh metodiv profilaktyky raku shyiky matky // Visn. sotsialnoi hihiieny ta orhanizatsii okhorony zdorovia Ukrainy. – 2012. – №. 4 – S. 38–41.

3. Lapii F. I. Ohliad svitovoho dosvidu vaktsynoprofilaktyky zakhvoriuvan, asotsiiovanykh iz virusom papilomy liudyny // Reproductive Endocrinology. – 2012. – № 8. – S. 30–33. https://doi.org/10.18370/2309-4117.2012.8.30-33

4. Vorsters A., Arbyn M., Baay M. et al. Overcoming barriers in HPV vaccination and screening programs // Papillomavirus Research. – 2017. – V. 4. – P. 45–53. https://doi.org/10.1016/j.pvr.2017.07.001

5. Gardner E. M., McLees M. P., Steiner J. F. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection // Clin. Infect. Dis. – 2011. – V. 52, N 6. – P. 793–800. https://doi.org/10.1093/cid/ciq243

6. Hnatko O. P., Skuriatina N. H., Berezhna T. A. Diahnostychne znachennia markeriv proliferatsii u vyznachenni stupenia vazhkosti peredrakovykh staniv shyiky matky // Akt. pytannia pediatrii, akusherstva ta hinekolohii. – 2018. – № 1. – S. 153. https://doi.org/10.11603/24116-4944.2018.1.8736

7. Ronco G. et al. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials // The lancet. – 2014. – V. 383, N 9916. – P. 524–532. https://doi.org/10.1016/S0140-6736(13)62218-7

8. Mudrak I. H., Zaliska O. M. Metodyka farmakoekonomichnoho analizu zasobiv roslynnoho pokhodzhennia, shcho vykorystovuiutsia pry likuvanni poshyrenykh urolohichnykh zakhvoriuvan v statsionari // Farmats. chasopys. – 2008. – № 2. – C. 23–26. https://doi.org/10.11603/2312-0967.2008.2.3065

9. Soloviov S. O., Kovaliuk O. V., Dziublyk I. V., Oliinyk O. A. Formuvannia metodolohii farmakoekonomichnoho analizu stratehii skryninhu patolohii-predyktoriv raku shyiky matky // Problemy viiskovoi okhorony zdorovia. – 2015. – Vyp. 44 (2). – S. 328–335.
Published
2019-10-29
How to Cite
Soloviov, S. O., Dziublyk, I. V., & Trokhymchuk, V. V. (2019). Conceptual foundations of pharmacoeconomic analysis of prevention technologies of chronic viral infections. Farmatsevtychnyi Zhurnal, (5), 35-43. https://doi.org/10.32352/0367-3057.5.19.04
Section
Pharmacoeconomics